Clinical trials sponsored by Dana-Farber Cancer Institute

Phase breakdown

Conditions studied

Recruiting trials led by Dana-Farber Cancer Institute

• A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
  NCT05899361 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
  NCT04434040 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Biology of Young Lung Cancer Study: The YOUNG LUNG Study
  NCT05265429 · Phase: Not specified · Ages: 15 Years and older · Sex: All (male and female) · 4 locations
• Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
  NCT07675967 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
  NCT07426484 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
  NCT06202183 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: All (male and female) · 1 location
• Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
  NCT05327465 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
  NCT05463796 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study
  NCT07123649 · Phase: Phase 2 · Ages: 80 Years and older · Sex: Female · 1 location
• Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
  NCT05587439 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
  NCT04789486 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
  NCT06488378 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial
  NCT06026111 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
  NCT06038318 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 25 Years · Sex: All (male and female) · 2 locations
• Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
  NCT06122896 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
  NCT07735624 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
  NCT05765500 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Resilience and Equity in Aging, Cancer, and Health (REACH)
  NCT04674267 · Phase: Not applicable (e.g. observational or device study) · Ages: 70 Years and older · Sex: All (male and female) · 1 location
• Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
  NCT05356117 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Scalp Cooling in MBC
  NCT04986579 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stereotactic Magnetic Resonance Guided Radiation Therapy
  NCT04115254 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Supporting Health Including Endocrine Treatment for Long Duration
  NCT07482384 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 49 Years · Sex: Female · 1 location
• TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
  NCT05535192 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: Female · 4 locations
• The COMPASSION Study
  NCT06507930 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
  NCT06565052 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Video Education With Result Dependent dIsclosure
  NCT05225428 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Dana-Farber Cancer Institute recruiting for?

Dana-Farber Cancer Institute is the lead sponsor of 26 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.